ClinicalTrials.Veeva

Menu

Mediators of Atherosclerosis in South Asians Living in America (MASALA)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Active, not recruiting

Conditions

Coronary Artery Disease
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Atherosclerosis

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT01207167
R01MD016071 (U.S. NIH Grant/Contract)
MASALA
R01HL149809 (U.S. NIH Grant/Contract)
R01HL093009 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

South Asian (Indian, Pakistani, Bangladeshi, Nepali, and Sri Lankan) individuals have high rates of cardiovascular disease that is not explained by traditional cardiovascular risk factors. Though South Asians represent over one-quarter of the world's population, there are no longitudinal studies in this high-risk ethnic group. The investigators aim to establish a longitudinal study of South Asians at three United States centers to identify risk factors linked to subclinical atherosclerosis and incident cardiovascular disease. The purpose of this study is to understand the causes of heart disease and stroke in South Asians and compare these causes to those in other United States ethnic groups.

Enrollment

2,314 estimated patients

Sex

All

Ages

40 to 84 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • South Asian ancestry defined by having at least 3 grandparents born in one of the following countries: India, Pakistan, Bangladesh, Nepal, or Sri Lanka
  • age between 40 and 84 years.

Exclusion criteria

  • Physician diagnosed heart attack, stroke or transient ischemic attack (TIA), heart failure, or angina (or use of nitroglycerin)
  • Current atrial fibrillation
  • Past history of cardiovascular procedures (coronary artery bypass graft (CABG) Surgery, angioplasty, valve replacement, pacemaker or defibrillator implantation, or any surgery on the heart or arteries)
  • Active treatment for cancer
  • Life expectancy less than 5 years due to serious medical illness
  • Impaired cognitive ability as judged by the reviewer
  • Plans to move out of the study region in next 5 years
  • Weight greater than 300 pounds
  • Living in a nursing home or on a waiting list
  • Unable to speak/read/write English, Hindi, Urdu, or Bangla

Trial contacts and locations

3

Loading...

Central trial contact

Alka Kanaya, MD; Ann Chang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems